# A Sub Study of the Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)

> **NCT05320146** · — · COMPLETED · sponsor: **Corcept Therapeutics** · enrollment: 22 (actual)

## Conditions studied

- Nonalcoholic Steatohepatitis (NASH)

## Interventions

- **OTHER:** MRI-PDFF

## Key facts

- **NCT ID:** NCT05320146
- **Lead sponsor:** Corcept Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-04
- **Primary completion:** 2023-07-18
- **Final completion:** 2023-07-18
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2024-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05320146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05320146, "A Sub Study of the Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05320146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*